|
| | (2S,4R)-Teneligliptin Basic information |
| Product Name: | (2S,4R)-Teneligliptin | | Synonyms: | Teneligptin API;((2S,4R)-4-(4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-yl)(thiazolidin-3-yl)Methanone;Teneligliptin (2S,4R)-Isomer;[(2S,4R)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone;3-{(2S,4R)-4-[4-(3-Methyl-1-phenyl-1H- pyrazol-5-yl)piperazin-1-yl]pyrrolidin -2-yl-carbonyl}thiazolidine;Methanone, [(2S,4R)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinyl-;Teneligliptin 2S,4R;Teneligliptin (2S,4R)-Isomer Impurity | | CAS: | 1404559-15-4 | | MF: | C22H30N6OS | | MW: | 426.58 | | EINECS: | | | Product Categories: | | | Mol File: | 1404559-15-4.mol |  |
| | (2S,4R)-Teneligliptin Chemical Properties |
| Boiling point | 663.4±55.0 °C(Predicted) | | density | 1.38±0.1 g/cm3(Predicted) | | pka | 8.70±0.10(Predicted) |
| | (2S,4R)-Teneligliptin Usage And Synthesis |
| Uses | (2S,4R)-Teneligliptin is a stereoisomer of Teneligliptin (T018300, HBr); a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used to treat type 2 diabetes. It is eliminated via excretion and has a half-life of 24.2 hours in the human body. |
| | (2S,4R)-Teneligliptin Preparation Products And Raw materials |
|
